Shenzhen Neptunus Interlong Bio-technique Company Limited

Shenzhen Neptunus Interlong Bio-technique Company Limitedverified

8329.HK

Price:

$0.143

Market Cap:

$217.84M

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, researches, develops, produces, and sells medicines in the People's Republic of China. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology products. In addition, the company manufactures herbal medicines and generic drugs products, as well as medical devices. The company is based in Shenzhen, the People's Republic of China. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2005-09-12

Stock Exchange

HKSE

Ticker

8329.HK

The Enterprise Value as of December 2025 (TTM) for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) is 180.41M

According to Shenzhen Neptunus Interlong Bio-technique Company Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 180.41M. This represents a change of -0.94% compared to the average of 182.13M of the last 4 quarters.

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Historical Enterprise Value (quarterly & annually)

How has 8329.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Shenzhen Neptunus Interlong Bio-technique Company Limited over the last ten years is 199.82M. The current 180.41M Enterprise Value has changed 8.93% with respect to the historical average. Over the past ten years (40 quarters), 8329.HK's Enterprise Value was at its highest in in the March 2016 quarter at 1.14B. The Enterprise Value was at its lowest in in the December 2023 quarter at -33153598.92.

Quarterly (TTM)
Annual

Average

199.82M

Median

108.29M

Minimum

-33161128.80

Maximum

753.36M

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shenzhen Neptunus Interlong Bio-technique Company Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 505.67%

Maximum Annual Enterprise Value = 753.36M

Minimum Annual Increase = -337.90%

Minimum Annual Enterprise Value = -33161128.80

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202478.89M-337.90%
2023-33161128.80-157.73%
202257.44M-56.27%
2021131.36M54.16%
202085.21M505.67%
201914.07M-92.99%
2018200.84M1.42%
2017198.03M-61.34%
2016512.18M-32.01%
2015753.36M-7.88%

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Average Enterprise Value

How has 8329.HK Enterprise Value performed in the past?

The current Enterprise Value of Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

34.39M

5-year avg

63.95M

10-year avg

199.82M

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Enterprise Value vs. Peers

How is 8329.HK’s Enterprise Value compared to its peers?

Shenzhen Neptunus Interlong Bio-technique Company Limited’s Enterprise Value is less than Extrawell Pharmaceutical Holdings Limited (266.57M), greater than Huakang Biomedical Holdings Company Limited (142.40M), less than Tianda Pharmaceuticals Limited (267.51M), less than Bamboos Health Care Holdings Limited (219.04M), less than Tycoon Group Holdings Limited (646.59M), less than Tai United Holdings Limited (1.55B), less than PuraPharm Corporation Limited (505.75M), greater than China Health Group Inc. (105.52M), less than Good Fellow Healthcare Holdings Limited (215.25M), greater than Regent Pacific Group Limited (45.53M),

Build a custom stock screener for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Neptunus Interlong Bio-technique Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shenzhen Neptunus Interlong Bio-technique Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Shenzhen Neptunus Interlong Bio-technique Company Limited's Enterprise Value?

What is the highest Enterprise Value for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)?

What is the 3-year average Enterprise Value for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)?

What is the 5-year average Enterprise Value for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)?

How does the current Enterprise Value for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) compare to its historical average?